Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strepsils Original lozenge saliva bioavailability study
2005-000974-29Phase 4Completed
- Sponsor
- Boots Healthcare International
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amylmetacresol + 2,4-dichlorobenzyl alcohol in Oral infections and pharyngitis, sponsored by Boots Healthcare International. Primary endpoints: Saliva concentrations of amylmetacresol and 2,4-dichlorobenzyl alcohol, Total saliva volume collected and 1 more. Started Mar 2005; status: completed.
02
Drugs
amylmetacresol + 2,4-dichlorobenzyl alcohol
03
Conditions
Oral infectionspharyngitis
Beyond the preview
Go deeper on 2005-000974-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000974-29.